AMPHASTAR PHARMACEUTICALS IN (AMPH)

US03209R1032 - Common Stock

41.648  +0.4 (+0.96%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
644.39M499.00M437.80M349.80M322.40M
Minority Interest Expense
N/A0.00-1.20M300.00K2.40M
Cost Of Goods
290.57M250.10M238.00M206.50M190.40M
Gross Profit
353.82M248.90M199.70M143.30M131.90M
Operating Expenses
154.13M141.40M129.90M132.40M132.00M
Research and Development
63.89M64.70M49.90M57.10M60.30M
Selling, General, and Administrative Expenses
80.39M66.60M68.90M65.20M63.10M
Operating Income
199.69M107.50M69.90M11.00M0.00
Interest Income/Expense
-18.70M-500.00K-300.00K300.00K900.00K
Other Income/Expense
-3.93M14.50M900.00K-6.60M59.40M
Non Recurring Items
-5.70M-5.40M13.60MN/AN/A
Income Before Taxes
171.36M116.00M84.10M4.60M60.20M
Income Tax
31.83M23.50M20.60M3.50M13.70M
Net Income
137.54M91.40M62.10M1.40M48.90M
EBITDA
237.72M132.74M93.39M32.53MN/A
 
Per Share Data
EPS Diluted Total Ops
2.601.741.250.030.98
Non GAAP EPS
3.301.971.360.640.35
 
Statistics
Gross Profit Margin
54.91%49.88%45.61%40.97%40.91%
Profit Margin
21.34%18.32%14.18%0.40%15.17%
Operating Profit Margin
30.99%21.54%15.97%3.14%N/A

All data in USD

Charts